Show simple item record

dc.contributor.advisor
dc.contributor.authorSchutte, Rudolph
dc.date.accessioned2017-02-24T06:31:17Z
dc.date.available2017-02-24T06:31:17Z
dc.date.issued2014
dc.identifier.urihttp://hdl.handle.net/10394/20536
dc.description.abstractBackground Albuminuria as determined from easily collected spot urine or 24 hour urine samples reflects general vascular damage, associates with left ventricular hypertrophy, and predicts adverse cardiovascular and renal outcomes. However, this easily measurable and low cost marker of cardiovascular risk is not yet included in the European, American and South African hypertension guidelines and evidence in Africans is limited. Methods We provide evidence of the usability of this marker in four papers from three different studies, i.e., the Sympathetic and Ambulatory and Ambulatory Blood Pressure in Africans (SABPA), the Prospective Urban Rural Epidemiological (PURE) study and the combination of the prospective ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) and The Telmisartan Randomised AssessmeNt Study in ACE iNtoleranT subjects with cardiovascular Disease (TRANSCEND) trials.
dc.language.isoenen_US
dc.publisherPotchefstroom : Noordwes-Universiteit, Potchefstroomkampusen_US
dc.subjectEducationen_US
dc.subjectPhilosophyen_US
dc.subjectOnderwysen_US
dc.subjectWysbegeerteen_US
dc.subjectMoral educationen_US
dc.subjectSedelike opvoedingen_US
dc.subjectNormativity (Ethics)en_US
dc.subjectElectronic booksen_US
dc.titleIt's all in a cup of "tea" / Rudolph Schutteen_US
dc.typeOtheren_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record